Role of levosimendan in the management of subarachnoid hemorrhage

American Journal of Emergency Medicine

Volumn 34, Issue 2, 2016, Pages 298-306

  Varvarousi, Giolanda ^a   Xanthos, Theodoros ^b   Sarafidou, Pavlina ^a   Katsioula, Ellisavet ^a,b   Georgiadou, Marianthi ^a   Eforakopoulou, Maria ^a,b   Pavlou, Hlias ^a,b  

^a KAT HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CYCLIC AMP; DOBUTAMINE; LEVOSIMENDAN; MILRINONE; CARDIOTONIC AGENT; HYDRAZONE DERIVATIVE; PYRIDAZINE DERIVATIVE; SIMENDAN;

ARTICLE; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN PERFUSION; HEART MUSCLE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; SUBARACHNOID HEMORRHAGE; COMPLICATION; MYOCARDIAL STUNNING;

CARDIOTONIC AGENTS; HUMANS; HYDRAZONES; MYOCARDIAL STUNNING; PYRIDAZINES; SUBARACHNOID HEMORRHAGE;

EID: 84957967639     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2015.11.024     Document Type: Review

References (101)

1. M.L. Hackett, and C.S. Anderson Health outcomes 1 year after subarachnoid hemorrhage: an international population-based study: the Australian Cooperative Research on Subarachnoid Hemorrhage Study Group Neurology 55 2000 658 662
2. S. Chen, H. Feng, P. Sherchan, D. Klebe, G. Zhao, X. Sun, and et al. Controversies and evolving new mechanisms in subarachnoid hemorrhage Prog Neurobiol 115 2014 64 91
3. M. Moussouttas, T.T. Huynh, J. Khoury, E.W. Lai, K. Dombrowski, S. Pello, and et al. Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage Cerebrovasc Dis 33 2012 173 181
4. J. Papanikolaou, V. Tsolaki, D. Makris, and E. Zakynthinos Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure Int J Cardiol 176 2014 1435 1437
5. V.S. Moiseyev, P. Poder, N. Andrejevs, M.Y. Ruda, A.P. Golikov, L.B. Lazebnik, and et al. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN) Eur Heart J 23 2002 1422 1432
6. S.G. Keyrouz, and M.N. Diringer Clinical review: prevention and therapy of vasospasm in subarachnoid hemorrhage Crit Care 11 2007 220 230
7. A.M. Arias, P.F. Oberti, R. Pizarro, M.L. Falconi, D.P. de Arenaza, S. Zeffiro, and et al. Dobutamine-precipitated takotsubo cardiomyopathy mimicking acute myocardial infarction Circulation 124 2011 312 315
8. S. Busani, L. Rinaldi, C. Severino, M. Cobelli, A. Pasetto, and M. Girardis Levosimendan in cardiac failure after subarachnoid hemorrhage J Trauma 68 2010 E108 E110
9. M. Endoh Mechanism of action of Ca2 + sensitizers - update. Cardiovasc Drugs Ther 2001;15:397-403. [See comment in PubMed Commons bel10] Taccone FS, Brasseur A, Vincent JL, De Backer D. Levosimendan for the treatment of subarachnoid hemorrhage-related cardiogenic shock Intensive Care Med 39 2013 1497 1498
10. P. Llorens-Soriano, J. Carbajosa-Dalmaua, J. Fernández-Cañadasa, J. Murcia Zaragoza, V. Climent-Payá, F. Laghzaouia, and et al. Clinical experience with levosimendan in the emergency department of a tertiary care hospital Rev Esp Cardiol 60 2007 878 882
11. C. King Listening to the head and not the heart: subarachnoid haemorrhage associated with severe acute left ventricular failure BMJ Case Rep 29 2013 2013 2017
12. A.M. Naidech, K.T. Kreiter, N. Janjua, N.D. Ostapkovich, A. Parra, C. Commichau, and et al. Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage Circulation 112 2005 2851 2856
13. J.G. Zaroff, G.A. Rordorf, C.S. Ogilvy, and M.H. Picard Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury J Am Soc Echocardiogr 13 2000 774 779
14. A.M. Elrifai, J.E. Bailes, S.R. Shih, S. Dianzumba, and J. Brillman Characterization of the cardiac effects of acute subarachnoid hemorrhage in dogs Stroke 27 1996 737 741
15. I.S. Wittstein, D.R. Thiemann, J.A. Lima, K.L. Baughman, S.P. Schulman, G. Gerstenblith, and et al. Neurohumoral features of myocardial stunning due to sudden emotional stress N Engl J Med 352 2005 539 548
16. A.R. Lyon, P.S. Rees, S. Prasad, P.A. Poole-Wilson, and S.E. Harding Stress (takotsubo) cardiomyopathy - a novel pathophysiological hypothesis to explain catecholamine- induced acute myocardial stunning Nat Clin Pract Cardiovasc Med 5 2008 22 29
17. Y. Kitagawa, D. Yamashita, H. Ito, and M. Takaki Reversible effects of isoproterenol induced hypertrophy on in situ left ventricular function in rat hearts Am J Physiol Heart Circ Physiol 287 2004 H277 H285
18. A.P. Beltrami, L. Barlucchi, D. Torella, M. Baker, F. Limana, S. Chimenti, and et al. Adult cardiac stem cells are multipotent and support myocardial regeneration Cell 114 2003 763 776
19. W.M. van den Bergh, A. Algra, and G.J. Rinkel Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage Stroke 35 2004 644 648
20. G. Baroldi, R.E. Mittleman, M. Parolini, M.D. Silver, and V. Fineschi Myocardial contraction bands. Definition, quantification and significance in forensic pathology Int J Legal Med 115 2001 142 151
21. A. Grad, T. Kiauta, and J. Osredkar Effect of elevated plasma norepinephrine on electrocardiographic changes in subarachnoid hemorrhage Stroke 22 1991 746 749
22. K.I. Melville, B. Blum, H.E. Shister, and M.D. Silver Cardiac ischemic changes and arrhythmias induced by hypothalamic stimulation Am J Cardiol 12 1963 781 789
23. L.L. Wu, S.L. Yang, R.C. Yang, H.K. Hsu, C. Hsu, L.W. Dong, and et al. G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis Shock 19 2003 533 537
24. R.P. Xiao, S.J. Zhang, K. Chakir, P. Avdonin, W. Zhu, R.A. Bond, and et al. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR) - but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts Circulation 108 2003 1633 1639
25. J.F. Heubach, M. Blaschke, S.E. Harding, U. Ravens, and A.J. Kaumann Cardiostimulant and cardiodepressant effects through overexpressed human 2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors Naunyn Schmiedebergs Arch Pharmacol 367 2003 380 390
26. A.R. Lyon, P.S. Rees, S. Prasad, P.A. Poole-Wilson, and S.E. Harding Stress (Takotsubo) cardiomyopathy - a novel pathophysiological hypo thesis to explain catecholamine induced acute myocardial stunning Nat Clin Pract Cardiovasc Med 5 2008 22 29
27. D.A. Heck, and D.B. Bylund Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes J Pharmacol Exp Ther 282 1997 1219 1227
28. B. Prunet, M. Basely, E. D'Aranda, P. Cambefort, F. Pons, S. Cimarelli, and et al. Impairment of cardiac metabolism and sympathetic innervation after aneurysmal subarachnoid hemorrhage: a nuclear medicine imaging study Crit Care 18 2014 R131 R140
29. Y.Y. Wang, S.Y. Lin, Y.H. Chuang, W.H. Sheu, K.C. Tung, and C.J. Chen Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats Endocrinology 155 2014 1235 1246
30. W.E. Clutter, D.M. Bier, S.D. Shah, and P.E. Cryer Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man J Clin Invest 66 1980 94 101
31. H.H. Lipowsky Microvascular rheology and hemodynamics Microcirculation 12 2005 5 15
32. S. Kumari, L. Anderson, S. Farmer, S.L. Mehta, and P.A. Li Hyperglycemia alters mitochondrial fission and fusion proteins in mice subjected to cerebral ischemia and reperfusion Transl Stroke Res 3 2012 296 304
33. V. Dilsizian, T.M. Bateman, S.R. Bergmann, R. Des Prez, M.Y. Magram, A.E. Goodbody, and et al. Metabolic imaging with betamethyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia Circulation 112 2005 2169 2174
34. J.A. Thompson, and M.L. Hess The oxygen free radical system: a fundamental mechanism in the production of myocardial necrosis Prog Cardiovasc Dis 28 1986 449 462
35. G.S. Behonick, M.J. Novak, E.W. Nealley, and S.I. Baskin Toxicology update: the cardiotoxicity of the oxidative stress metabolites of catecholamines (aminochromes) J Appl Toxicol 21 2001 S15 S22
36. M. Neri, D. Cerretani, A.I. Fiaschi, P.F. Laghi, P.E. Lazzerini, A.B. Maffione, and et al. Correlation between cardiac oxidative stress and myocardial pathology due to acute and chronic norepinephrine administration in rats J Cell Mol Med 11 2007 156 170
37. J.F. Heubach, U. Ravens, and A.J. Kaumann Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart Mol Pharmacol 65 2004 1313 1322
38. S. Kohsaka, V. Menon, A.M. Lowe, M. Lange, V. Dzavik, L.A. Sleeper, and et al. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock Arch Intern Med 165 2005 1643 1650
39. Y.L. Sakr, I. Ghosn, and J.L. Vincent Cardiac manifestations after subarachnoid hemorrhage: a systematic review of the literature Prog Cardiovasc Dis 45 2002 67 80
40. M.D. Aydin, A. Kanat, A. Yilmaz, M. Cakir, M. Emet, Z. Cakir, and et al. The role of ischemic neurodegeneration of the nodose ganglia on cardiac arrest after subarachnoid hemorrhage: an experimental study Exp Neurol 230 2011 90 95
41. C.C. Huang, C.H. Huang, H.Y. Kuo, C.M. Chan, J.H. Chen, and W.L. Chen The 12-lead electrocardiogram in patients with subarachnoid hemorrhage: early risk prognostication Am J Emerg Med 30 2012 732 736
42. S.A. Mayer, M.E. Fink, S. Homma, D. Sherman, G. LiMandri, L. Lennihan, and et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemorrhage Neurology 44 1994 815 820
43. J. Papanikolaou, D. Makris, D. Karakitsos, T. Saranteas, A. Karabinis, G. Kostopanagiotou, and et al. Cardiac and central vascular functional alterations in the acute phase of aneurysmal subarachnoid hemorrhage Crit Care Med 40 2012 223 232
44. S.C. Deehan, and I.S. Grant Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine Intensive Care Med 22 1996 672 676
45. A. Naidech, Y. Du, K.T. Kreiter, A. Parra, B.F. Fitzsimmons, S.D. Lavine, and et al. Dobutamine versus milrinone after subarachnoid hemorrhage Neurosurgery 56 2005 21 26
46. F. Despas, C. Trouillet, N. Franchitto, M. Labrunee, M. Galinier, J.M. Senard, and et al. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording Acute Card Care 12 2010 25 30
47. R. Margey, P. Diamond, H. McCann, and D. Sugrue Dobutamine stress echo induced apical ballooning syndrome Eur J Echocardiogr 10 2009 395 399
48. R. Saito, T. Takahashi, N. Noshita, A. Narisawa, K. Negi, K. Takei, and et al. Takotsubo cardiomyopathy induced by dobutamine infusion during hypertensive therapy for symptomaticvasospasm after subarachnoid hemorrhage - case report Neurol Med Chir (Tokyo) 50 2010 393 395
49. J. Lilleberg, M. Laine, T. Palkama, M. Kivikko, P. Pohjanjousi, and M. Kupari Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure Eur J Heart Fail 9 2007 75 82
50. S.V. Perrone, and E.J. Kaplinsky Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure Int J Cardiol 103 2005 248 255
51. J.J. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, and et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
52. C. Antoniades, A.S. Antonopoulos, D. Tousoulis, C. Bakogiannis, E. Stefanadi, and C. Stefanadis Relationship between the pharmacokinetics of levosimendan and its effects on cardiovascular system Curr Drug Metab 10 2009 95 103
53. S. Treskatsch, F. Balzer, T. Geyer, C.D. Spies, M. Kastrup, H. Grubitzsch, and et al. Early levosimendan administration is associated with decreased mortality after cardiac surgery J Crit Care 30 2015 859.e1 859.e6
54. H. Paur, P.T. Wright, M.B. Sikkel, M.H. Tranter, C. Mansfield, P. O'Gara, and et al. High levels of circuating epinephrine trigger apical cardiopression in a β-2 adrenergic receptor/Gi-dependent manner: a new model of Takotsubo cardiomyopathy Circulation 126 2012 697 706
55. J.G. Cleland, and J. McGowan Levosimendan: a new era for inodilator therapy for heart failure? Curr Opin Cardiol 17 2002 257 265
56. V.S. Moiseyev, P. Põder, N. Andrejevs, M.Y. Ruda, A.P. Golikov, L.B. Lazebnik, and et al. Safety and efficacy of a novel calcium sensitizer, levosimendan in patients with left ventricular due to an acute myocardial infarction. A randomized placebo-controlled double blind study (RUSSLAN) Eur Heart J 23 2002 1422 1432
57. G. Aidonidis, I. Kanonidis, V. Koutsimanis, T. Neumann, R. Erbel, and G. Sakadamis Efficiency and safety of prolonged levosimendan infusion in patients with acute heart failure Cardiol Res Pract 2011 2011 342302 342308
58. M.T. Slawsky, W.S. Colucci, S.S. Gottlieb, B.H. Greenberg, E. Haeusslein, J. Hare, and et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure Circulation 102 2000 2222 2227
59. S. Sonntag, S. Sundberg, L.A. Lehtonen, and F.X. Kleber The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia J Am Coll Cardiol 43 2004 2177 2182
60. X. Wu, J. Wu, X. Yan, and Y. Zhang Enhancement of myocardial function and reduction of injury with levosimendan after percutaneous coronary intervention for acute myocardial infarction: a pilot study Cardiology 128 2014 202 208
61. C. Avgeropoulou, I. Andreadou, S. Markantonis-Kyroudis, M. Demopoulou, P. Missovoulos, A. Androulakis, and et al. The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine Eur J Heart Fail 7 2005 882 887
62. D.J. Milligan, and A.M. Fields Levosimendan: calcium sensitizer and inodilator Anesthesiol Clin 28 2010 753 760
63. M. Maytin, and W.S. Colucci Cardioprotection: a new paradigm in the management of acute heart failure syndromes Am J Cardiol 96 2005 26G 31G
64. J.T. Parissis, I. Andreadou, S.L. Markantonis, V. Bistola, A. Louka, A. Pyriochou, and et al. Effects of levosimendan on circulating markers of oxidative and nitrosative stress in patients with advanced heart failure Atherosclerosis 195 2007 e210 e215
65. J.D. McCully, and S. Levitsky Mitochondrial ATP-sensitive potassium channels in surgical cardioprotection Arch Biochem Biophys 420 2003 237 245
66. J.T. Parissis, S. Adamopoulos, C. Antoniades, G. Kostakis, A. Rigas, S. Kyrzopoulos, and et al. Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure Am J Cardiol 93 2004 1309 1312
67. J. Cahill, and J.H. Zhang Subarachnoid hemorrhage: is it time for a new direction? Stroke 40 2009 86 87
68. J.I. Suarez, R.W. Tarr, and W.R. Selman Aneurysmal subarachnoid hemorrhage N Engl J Med 354 2006 387 396
69. E.M. Manno, D.R. Gress, L.H. Schwamm, M.N. Diringer, and C.S. Ogilvy Effects of induced hypertension on transcranial Doppler ultrasound velocities in patients after subarachnoid hemorrhage Stroke 29 1998 422 428
70. R.E. Ayer, and J.H. Zhang The clinical significance of acute brain injury in subarachnoid hemorrhage and opportunity for intervention Acta Neurochir Suppl 105 2008 179 184
71. P. Tung, A. Kopelnik, N. Banki, K. Ong, N. Ko, M.T. Lawton, and et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage Stroke 35 2004 548 551
72. D. Özsavcí, M. Erşahin, A. Şener, Ö.B. Özakpinar, H.Z. Toklu, D. Akakín, and et al. The novel function of nesfatin-1 as an anti-inflammatory and antiapoptotic peptide in subarachnoid hemorrhage-induced oxidative brain damage in rats Neurosurgery 68 2011 1699 1708
73. Y. Liu, X. Yang, H. Gong, B. Jiang, H. Wang, G. Xu, and et al. Assessing the effects of norepinephrine on single cerebral microvessels using opticalresolution photoacoustic microscope J Biomed Opt 18 2013 76007
74. J. Claassen, J.R. Carhuapoma, K.T. Kreiter, E.Y. Du, E.S. Connolly, and S.A. Mayer Global cerebral edema after subarachnoid hemorrhage: frequency, predictors, and impact on outcome Stroke 33 2002 1225 1232
75. S. Strandgaard, and O.B. Paulson Cerebral autoregulation Stroke 15 1984 413 416
76. H. Basel, S. Kavak, H. Demir, I. Meral, H. Ekim, and H. Bektas Effect of levosimendan injection on oxidative stress of rat myocardium Toxicol Ind Health 29 2013 435 440
77. M.T. Nelson, and J.M. Quayle Physiological roles and properties of potassium channels in arterial smooth muscle Am J Physiol 268 1995 C799 C822
78. P.I. Johansson, N. Haase, A. Perner, and S.R. Ostrowski Association between sympathoadrenal activation, fibrinolysis, and endothelial damage in septic patients: a prospective study J Crit Care 29 2014 327 333
79. T. Ogura, A. Satoh, H. Ooigawa, T. Sugiyama, R. Takeda, G. Fushihara, and et al. Characteristics and prognostic value of acute catecholamine surge in patients with aneurysmal subarachnoid hemorrhage Neurol Res 34 2012 484 490
80. J. Han, N. Kim, H. Joo, E. Kim, and Y.E. Earm ATP sensitive K(+) channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes Am J Physiol Heart Circ Physiol 283 2002 H1545 H1554
81. C.G. Sobey, and F.M. Faraci Subarachnoid haemorrhage: what happens to the cerebral arteries Clin Exp Pharmacol Physiol 25 1998 867 876
82. S.L. Cengiz, M.F. Erdi, M. Tosun, E. Atalik, M.C. Avunduk, F.C. Sönmez, and et al. Beneficial effects of levosimendan on cerebral vasospasm induced by subarachnoid haemorrhage: an experimental study Brain Inj 24 2010 877 885
83. H. Caner, A.L. Kwan, M. Bavbek, K. Kilinc, M. Durieux, K. Lee, and et al. Systemic administration of mexiletine for attenuation of cerebral vasospasm following experimental subarachnoid haemorrhage Acta Neurochir (Wien) 142 2000 455 461
84. J.P. Dreier, S. Major, A. Manning, J. Woitzik, C. Drenckhahn, J. Steinbrink, and et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurismal subarachnoid haemorrhage Brain 132 2009 1866 1881
85. B.J. Gwag, L.M. Canzoniero, S.L. Sensi, J.A. Demaro, J.Y. Koh, M.P. Goldberg, and et al. Calcium ionophores can induce either apoptosis or necrosis in cultured cortical neurons Neuroscience 90 1999 1339 1348
86. C. Barry, R.J. Turner, F. Corrigan, and R. Vink New therapeutic approaches to subarachnoid hemorrhage Expert Opin Investig Drugs 21 2012 845 859
87. N. Rondeau, R. Cinotti, B. Rozec, A. Roquilly, H. Floch, N. Groleau, and et al. Dobutamine-induced high cardiac index did not prevent vasospasm in subarachnoid hemorrhage patients: a randomized controlled pilot study Neurocrit Care 17 2012 183 190
88. E. Tonnesen, and C. Wahlgreen Influence of extradural and general anaesthesia on natural killer cell activity and lymphocyte subpopulations in patients undergoing hysterectomy Br J Anaesth 60 1988 500 507
89. K. Fassbender, B. Hodapp, S. Rossol, T. Bertsch, J. Schmeck, S. Schütt, and et al. Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries J Neurol Neurosurg Psychiatry 70 2001 534 537
90. C.S. Robertson, A.B. Valadka, H.J. Hannay, C.F. Contant, S.P. Gopinath, M. Cormio, and et al. Prevention of secondary ischemic insults after severe head injury Crit Care Med 27 1999 2086 2095
91. M. Joseph, S. Ziadi, J. Nates, M. Dannenbaum, and M. Malkoff Increases in cardiac output can reverse flow deficits from vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow Neurosurgery 53 2003 1044 1051
92. M.L. Levy, C.H. Rabb, V. Zelman, and S.L. Giannotta Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm J Neurosurg 79 1993 494 499
93. J. Konczalla, J. Mrosek, S. Wanderer, P. Schuss, E. Guresir, V. Seifert, and et al. Functional effects of levosimendan in rat basilar arteries in vitro Curr Neurovasc Res 10 2013 126 133
94. R.F. Kelm, J. Wagenführer, H. Bauer, I. Schmidtmann, K. Engelhard, and R.R. Noppens Effects of levosimendan on hemodynamics, local cerebral blood flow, neuronal injury, and neuroinflammation after asphyctic cardiac arrest in rats Crit Care Med 42 2014 e410 e419
95. M. Kivikko, M. Kuoppamaki, L. Soinne, S. Sundberg, P. Pohjanjousi, J. Ellmen, and et al. Oral levosimendan increases cerebral blood flow velocities in patients with a history of stroke or transient ischemic attack: a pilot safety study Curr Ther Res Clin Exp 77 2015 46 51
96. M.C. Bravo, P. López, F. Cabañas, J. Pérez-Rodríguez, E. Pérez-Fernández, J. Quero, and et al. Acute effects of levosimendanon cerebral and systemic perfusion and oxygenation in newborns: an observational study Neonatology 99 2011 217 223
97. J. Levijoki, M. Kivikko, P. Pollesello, J. Sallinen, M. Hyttilä-Hopponen, M. Kuoppamäki, and et al. Levosimendan alone and in combination with valsartan prevents stroke in Dahl salt-sensitive rats Eur J Pharmacol 750 2015 132 140
98. M. Hein, N. Zoremba, C. Bleilevens, C. Bruells, R. Rossaint, and A.B. Roehl Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model BMC Neurol 13 2013 106 114
99. B. Lafci, H. Yasa, G. Ilhan, R. Ortac, L. Yilik, M. Kestelli, and et al. Protection of the spinal cord from ischemia: comparative effects of levosimendan and iloprost Eur Surg Res 41 2008 1 7
100. A.B. Roehl, M. Hein, P.D. Loetscher, J. Rossaint, J. Weis, R. Rossaint, and et al. Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury BMC Neurol 10 2010 97 101
101. S.F. Katircioglu, M. Seren, A.I. Parlar, N.N. Turan, Y. Manavbasi, G. Aydog, and et al. Levosimendan effect on spinal cord ischemia-reperfusion injury following aortic clamping J Card Surg 23 2008 44 48